126 related articles for article (PubMed ID: 18540857)
1. Understanding cost effectiveness: money matters?
Sprague S; Quigley L; Adili A; Bhandari M
J Long Term Eff Med Implants; 2007; 17(2):145-52. PubMed ID: 18540857
[TBL] [Abstract][Full Text] [Related]
2. The economic evaluation of medical devices: challenges.
Kingkaew P; Teerawattananon Y
J Med Assoc Thai; 2014 May; 97 Suppl 5():S102-7. PubMed ID: 24964706
[TBL] [Abstract][Full Text] [Related]
3. MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS.
Akpinar I; Jacobs P; Husereau D
Int J Technol Assess Health Care; 2015 Jan; 31(1-2):86-9. PubMed ID: 25989920
[TBL] [Abstract][Full Text] [Related]
4. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.
Simpson EL; Duenas A; Holmes MW; Papaioannou D; Chilcott J
Health Technol Assess; 2009 Mar; 13(17):iii, ix-x, 1-154. PubMed ID: 19331797
[TBL] [Abstract][Full Text] [Related]
5. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?
Tarricone R; Torbica A; Ferré F; Drummond M
Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):707-18. PubMed ID: 25196848
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.
Thurgar E; Barton S; Karner C; Edwards SJ
Health Technol Assess; 2016 Mar; 20(24):v-vi, 1-486. PubMed ID: 27034016
[TBL] [Abstract][Full Text] [Related]
7. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
8. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic properties of medical devices: considerations for economic evaluation.
Basu R; Eggington S
Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):619-626. PubMed ID: 31721598
[No Abstract] [Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Huxley N; Crathorne L; Varley-Campbell J; Tikhonova I; Snowsill T; Briscoe S; Peters J; Bond M; Napier M; Hoyle M
Health Technol Assess; 2017 Jun; 21(38):1-294. PubMed ID: 28682222
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
12. Value for money in the health sector: the contribution of primary health care.
Mills A; Drummond M
Health Policy Plan; 1987 Jun; 2(2):107-28. PubMed ID: 10312103
[TBL] [Abstract][Full Text] [Related]
13. Addressing the need for economic evaluation of cardiovascular medical devices in India.
Masurkar PP
Curr Probl Cardiol; 2024 Aug; 49(8):102677. PubMed ID: 38795804
[TBL] [Abstract][Full Text] [Related]
14. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
Frampton G; Harris P; Cooper K; Lotery A; Shepherd J
Health Technol Assess; 2014 Nov; 18(68):1-205, v-vi. PubMed ID: 25405576
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: protocol for an economic evaluation alongside the SITLESS three-armed pragmatic randomised controlled trial.
Deidda M; Coll-Planas L; Giné-Garriga M; Guerra-Balic M; Roqué I Figuls M; Tully MA; Caserotti P; Rothenbacher D; Salvà Casanovas A; Kee F; Blackburn NE; Wilson JJ; Skjødt M; Denkinger M; Wirth K; McIntosh E;
BMJ Open; 2018 Oct; 8(10):e022266. PubMed ID: 30327403
[TBL] [Abstract][Full Text] [Related]
17. Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review.
Pease A; Lo C; Earnest A; Liew D; Zoungas S
Syst Rev; 2018 Mar; 7(1):44. PubMed ID: 29530081
[TBL] [Abstract][Full Text] [Related]
18. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
